289 related articles for article (PubMed ID: 25916999)
61. Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells.
Doğan F; Özateş NP; Bağca BG; Abbaszadeh Z; Söğütlü F; Gasımlı R; Gündüz C; Biray Avcı Ç
J Cell Biochem; 2019 Feb; 120(2):1282-1293. PubMed ID: 30368861
[TBL] [Abstract][Full Text] [Related]
62. Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
Shimo T; Kurebayashi J; Kanomata N; Yamashita T; Kozuka Y; Moriya T; Sonoo H
Breast Cancer; 2014 Jan; 21(1):75-85. PubMed ID: 22454224
[TBL] [Abstract][Full Text] [Related]
63. Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line.
Aborehab NM; Elnagar MR; Waly NE
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22638. PubMed ID: 33002289
[TBL] [Abstract][Full Text] [Related]
64. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
Pandya VA; Crerar H; Mitchell JS; Patani R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
[TBL] [Abstract][Full Text] [Related]
65. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
Bellat V; Verchère A; Ashe SA; Law B
BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
[TBL] [Abstract][Full Text] [Related]
66. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
67. BIBR1532 Affects Endometrial Cell Proliferation, Migration, and Invasion in Endometriosis via Telomerase Inhibition and MAPK Signaling.
Zhao X; Luo D; Liu T; Zhang H; Xie Y; Kong W
Gynecol Obstet Invest; 2023; 88(4):226-239. PubMed ID: 37429261
[TBL] [Abstract][Full Text] [Related]
68. +TIP EB1 downregulates paclitaxel‑induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules.
Thomas GE; Sreeja JS; Gireesh KK; Gupta H; Manna TK
Int J Oncol; 2015 Jan; 46(1):133-46. PubMed ID: 25310526
[TBL] [Abstract][Full Text] [Related]
69. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3.
Yang MY; Wang CJ; Chen NF; Ho WH; Lu FJ; Tseng TH
Chem Biol Interact; 2014 Apr; 213():60-8. PubMed ID: 24525192
[TBL] [Abstract][Full Text] [Related]
70. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
Duarte D; Cardoso A; Vale N
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
[TBL] [Abstract][Full Text] [Related]
71. Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs.
Cesmeli S; Goker Bagca B; Caglar HO; Ozates NP; Gunduz C; Biray Avci C
Med Oncol; 2021 Nov; 39(1):12. PubMed ID: 34779924
[TBL] [Abstract][Full Text] [Related]
72. [Effect of combined use of PDTC and paclitaxel on proliferation and invasion of human breast cancer cell line MCF-7].
Yang C; Zhang H; Huang W; Lin Q; Wei H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1105-9. PubMed ID: 21089680
[TBL] [Abstract][Full Text] [Related]
73. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
74. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
Snyder RM; Yu W; Jia L; Sanders BG; Kline K
Nutr Cancer; 2008; 60(3):401-11. PubMed ID: 18444175
[TBL] [Abstract][Full Text] [Related]
75. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.
Baselga J; Norton L; Albanell J; Kim YM; Mendelsohn J
Cancer Res; 1998 Jul; 58(13):2825-31. PubMed ID: 9661897
[TBL] [Abstract][Full Text] [Related]
76. Synergistic effect of paclitaxel and verapamil to overcome multi-drug resistance in breast cancer cells.
Li P; Zhong D; Gong PY
Biochem Biophys Res Commun; 2019 Aug; 516(1):183-188. PubMed ID: 31204050
[TBL] [Abstract][Full Text] [Related]
77. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
[TBL] [Abstract][Full Text] [Related]
78. Effect of curcumin and paclitaxel on breast carcinogenesis.
Quispe-Soto ET; Calaf GM
Int J Oncol; 2016 Dec; 49(6):2569-2577. PubMed ID: 27779649
[TBL] [Abstract][Full Text] [Related]
79. Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.
Shafer A; Zhou C; Gehrig PA; Boggess JF; Bae-Jump VL
Int J Cancer; 2010 Mar; 126(5):1144-54. PubMed ID: 19688827
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
